Researchers identify possible therapy for Alzheimer’sMarch 15th, 2008 - 11:36 am ICT by admin
Washington, March 15 (IANS) Curbing excess production of a peptide associated with Alzheimer’s disease could potentially show the way to a therapy where none currently exists, according to University of California researchers The study led by Vivian Y.H. Hook, findings of which have been published in the latest issue of the Journal of Biological Chemistry, demonstrated substantial memory improvement in an animal model of Alzheimer’s.
The disease is characterised by accumulation of amyloid plaque deposits, noticed during autopsy of the patient’s brain. The plaque is composed primarily of neurotoxic beta-amyloid (AB) peptide, believed to be a major factor in causing Alzheimer’s.
These peptides are ‘cut’ out from a larger protein called the amyloid precursor protein (APP) and bind together to form plaques in brain regions responsible for memory. One drug strategy to fight Alzheimer’s disease is to reduce production of AB.
“We discovered two chemical compounds that inhibit a new enzyme target, leading to reduced production of AB and improved memory in a mouse model of Alzheimer’s disease. After drug treatment, using water maze memory tests, we found that the mice exhibited great improvement in their memory, as well as reduced brain levels of beta amyloid.
“These results are consistent with previous research indicating that a different protease, called Cathepsin B (CatB), is elevated in brains of Alzheimer patients,” said Hook.
She added that a drug that duplicates this reduction by targeting CatB in humans could be an effective treatment for Alzheimer’s disease in the more than 99 percent people with the normal beta-secretase site.
“By disabling the enzyme’s ability to cut the ‘beta’ end of the amino acid sequence, researchers may discover a way to limit production of neurotoxic AB and reduce amyloid plaques in the brain.”
- Asthma drug could help fight Alzheimer's disease - Mar 26, 2011
- Asthma drug could help fight Alzheimer's - Mar 27, 2011
- Scientists eliminate plaque formation in Alzheimer's - Sep 06, 2012
- Scientists unveil potential Alzheimer's disease drug target - Mar 15, 2008
- Alzheimer's drug not as harmful as believed - Jun 18, 2010
- Liver, not brain, may be source of Alzheimer's plaques - Mar 04, 2011
- Drug reverses Alzheimer's symptoms in mice: Study - Feb 10, 2012
- New strategy to eliminate toxic proteins from brains of Alzheimers patients - Oct 24, 2008
- New method to cleanse brain of Alzheimer's plaques developed - Dec 10, 2010
- Drug reversing Alzheimer's symptoms found - Feb 12, 2012
- How Alzheimer's plaques lead to loss of nitric oxide in brain - Jan 11, 2011
- Blood vessel dysfunction linked to heart disease also plays role in Alzheimer's - Dec 03, 2010
- Second molecule in Alzheimer's toxic duo identified - Feb 04, 2011
- Tobacco-derived compound prevents memory loss in Alzheimer's - Apr 28, 2011
- Key target molecule for Alzheimer's therapy identified - Jul 31, 2010
Tags: alzheimer patients, amino acid sequence, amyloid plaques, amyloid precursor protein, animal model, beta amyloid, brain levels, brain regions, california researchers, catb, chemical compounds, drug strategy, excess production, journal of biological chemistry, memory improvement, memory tests, mouse model, plaque deposits, target, water maze